JNCCN 360 - BiomarkerNTRK

Biomarker NTRK Coverage from Every Angle

ABOUT
SECTIONS
NCCN RESOURCES
360 HUB
JNCCN

Editors:

Alexander Drilon, MD

Gregory J. Riely, MD, PhD

Videos

Gregory J. Riely, MD, PhD, on Identifying Patients With NTRK Fusions

Gregory J. Riely, MD, PhD, on the Clinical Impact of Targeting NTRK Gene Fusion in Advanced Cancers

Alexander Drilon, MD, on NTRK Fusion Basics: An Expert Overview

Alexander Drilon, MD, on Understanding the Structure of NTRK Fusions and Their Actionable Targets

Alexander Drilon, MD: Where Can NTRK Fusions Be Found?

Shivaani Kummar, MD, on TRK Fusion–Positive Cancer: Clinical Implications of Larotrectinib Treatment

John A. Bridgewater, MD, PhD, on Prognosis and Molecular Characteristics of Tumors With TRK Fusion

JNCCN Spotlights ?

Larotrectinib

Resources

For Cancer Care

NCCN Biomarkers Compendium

ASCO: COVID-19 Medical Resources

JNCCN: How To Manage Cancer Care During COVID-19 Pandemic

The ASCO Post Video Roundtable: Updates in Lung Cancer

Sections

NCCN Resources

360 HUB
About
Contact
Disclaimer
Disclosures
Privacy Policy
Terms Of Use

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.

Bots not welcome here